Elypta
7 known investors
Find your way into Elypta
Elypta develops a metabolism-based liquid biopsy that measures the GAGome, a set of biomarkers of tumor metabolism, and applies machine learning to noninvasively detect cancer signatures. The company focuses on early cancer detection to reduce cancer mortality.
Founders & leadership
FG
Francesco GattoFounder and Scientific Advisor
JN
Jens NielsenChairman, Founder
Investors · 7
Funding
SEC filings, press & company announcements$21M disclosed across 1 round · 2022
- $21MraisedJun 2022 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Elypta do?
- Elypta develops a metabolism-based liquid biopsy that measures the GAGome, a set of biomarkers of tumor metabolism, and applies machine learning to noninvasively detect cancer signatures. The company focuses on early cancer detection to reduce cancer mortality.
- Who founded Elypta?
- Elypta was founded by Francesco Gatto, Jens Nielsen.
- Who are Elypta's investors?
- Elypta's investors include Bonnier Capital, Chalmers Ventures AB, Industrifonden, Navigare Ventures, Nina Capital, Norrsken VC, Sciety.
- How much funding has Elypta raised?
- Elypta has disclosed $21M raised across 1 round.